These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11361230)

  • 1. In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects.
    Ho SC; Tai ES; Eng PH; Tan CE; Fok AC
    Singapore Med J; 2001 Jan; 42(1):6-10. PubMed ID: 11361230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults.
    Mhurchu CN; Poppitt SD; McGill AT; Leahy FE; Bennett DA; Lin RB; Ormrod D; Ward L; Strik C; Rodgers A
    Int J Obes Relat Metab Disord; 2004 Sep; 28(9):1149-56. PubMed ID: 15311218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in serum LDL cholesterol with microcrystalline chitosan.
    Wuolijoki E; Hirvelä T; Ylitalo P
    Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):357-61. PubMed ID: 10420392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial.
    Bokura H; Kobayashi S
    Eur J Clin Nutr; 2003 May; 57(5):721-5. PubMed ID: 12771974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
    Greyling A; De Witt C; Oosthuizen W; Jerling JC
    Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of yoghurt enriched with free plant sterols on the levels of serum lipids and plant sterols in moderately hypercholesterolaemic subjects on a high-fat diet.
    Niittynen LH; Jauhiainen TA; Poussa TA; Korpela R
    Int J Food Sci Nutr; 2008 Aug; 59(5):357-67. PubMed ID: 18979616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia.
    Tai ES; Fok AC; Chu R; Tan CE
    Ann Acad Med Singap; 1999 Mar; 28(2):209-13. PubMed ID: 10497668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet.
    Derosa G; Mugellini A; Ciccarelli L; Fogari R
    Clin Ther; 2003 Apr; 25(4):1107-22. PubMed ID: 12809960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects.
    Birketvedt GS; Travis A; Langbakk B; Florholmen JR
    Nutrition; 2002 Sep; 18(9):729-33. PubMed ID: 12297207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N; James WP; Kopelman PG; Lean ME; Williams G
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
    McKenney JM; Jenks BH; Shneyvas E; Brooks JR; Shenoy SF; Cook CM; Maki KC
    J Acad Nutr Diet; 2014 Feb; 114(2):244-249. PubMed ID: 24287284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.
    Ferguson JJA; Stojanovski E; MacDonald-Wicks L; Garg ML
    Metabolism; 2018 May; 82():22-35. PubMed ID: 29291429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind trial of chitosan for body weight reduction.
    Pittler MH; Abbot NC; Harkness EF; Ernst E
    Eur J Clin Nutr; 1999 May; 53(5):379-81. PubMed ID: 10369493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: a long-term placebo-controlled trial in hypercholesterolaemic volunteers.
    Lehtimäki T; Metso S; Ylitalo R; Rontu R; Nikkilä M; Wuolijoki E; Ylitalo P
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):98-103. PubMed ID: 15998356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects.
    Hermansen K; Hansen B; Jacobsen R; Clausen P; Dalgaard M; Dinesen B; Holst JJ; Pedersen E; Astrup A
    Eur J Clin Nutr; 2005 Jul; 59(7):843-50. PubMed ID: 15900307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
    JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH; Donovan JM; Misir S; Jones MR
    Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Chungkookjang supplementation on obesity and atherosclerotic indices in overweight/obese subjects: a 12-week, randomized, double-blind, placebo-controlled clinical trial.
    Back HI; Kim SR; Yang JA; Kim MG; Chae SW; Cha YS
    J Med Food; 2011 May; 14(5):532-7. PubMed ID: 21434780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.